English
Swedish

Home
About DexTech
Technology
Clinical Research
Prostate cancer
Investors
Press releases
Contact

Home
About DexTech
Technology
Clinical Research
Prostate cancer
Investors
Press releases
Contact

211108 – PM – Dextech -Styrelsen i DexT ech föreslår en företrädesemission

8 November, 2021

211108 - PM - Dextech -Styrelsen i DexT ech föreslår en företrädesemission

« The Board of Directors of DexTech proposes a rights issue of approx. MSEK 58.2 in order to further develop the project with multiple myeloma to clinical research and further verify OsteoDex’s value

Contact

Office address:
Dag Hammarskjölds Väg 34A, 752 37 Uppsala

Postal address:
Box 389, 751 06 Uppsala

Tel.:
+46 (0) 70 710 47 88

E-mail:
gosta.lundgren@dextechmedical.com

Home
About DexTech
Technology
Clinical Research
Prostate cancer
Investors
Press releases
Contact

© 2014-2025 DexTech Medical AB. All rights reserved. | xhtml 1.0 | plucera webbyrå

We use cookies to ensure that we give you the best experience on our website.
If you continue to use this site we will assume that you are happy with it.Ok